HSG（原红杉中国）已收购中国医疗级镍钛材料及精密零部件制造商PeierTech约80%的股份，以拓展其医疗健康投资组合。
HSG, formerly known as Sequoia China, has acquired an approximately 80% stake in PeierTech, a Chinese manufacturer of medical-grade nitinol materials and precision components, as the investment firm expands its healthcare portfolio.
PeierTech周四在声明中表示，该交易使HSG获得控股权，而公司现有管理团队保留剩余股权，并将继续负责日常运营。
The transaction gives HSG a controlling interest in PeierTech, while the company’s existing management team retains the remaining equity and will continue to oversee day-to-day operations, PeierTech said in a statement on Thursday.
HSG还计划为核心管理层推出基于市场的股权激励计划，以支持公司的增长和国际化扩张。
HSG also plans to introduce a market-based equity incentive programme for key management members to support the company’s growth and international expansion.
PeierTech成立于2002年，总部位于江苏省江阴市，向20多个国家的医疗器械制造商供货。其产品和服务包括镍钛丝和管材、精密加工及器械组装，应用领域涵盖心血管、神经血管、胃肠道和骨科医学。
Founded in 2002 and headquartered in Jiangyin, Jiangsu province, PeierTech supplies medical device manufacturers in more than 20 countries. Its products and services include nitinol wire and tubing, precision processing and device assembly for applications spanning cardiovascular, neurovascular, gastrointestinal and orthopaedic medicine.
该公司还具备激光切割和焊接、热处理、表面处理、编织及精密组装等制造能力。
The company also offers manufacturing capabilities including laser cutting and welding, heat treatment, surface finishing, braiding and precision assembly.
HSG合伙人贾斯蒂夫表示：“PeierTech凭借深厚的技术专长和长期的客户关系，在高度专业化的医疗器械制造细分领域确立了全球领先地位。我们看到通过国际化扩张、运营改进和市场整合，进一步巩固其全球地位的重大机遇。”
“PeierTech has established a leading global position in a highly specialised segment of medical device manufacturing, built on deep technical expertise and longstanding customer relationships. We see significant opportunities to further strengthen its global position through international expansion, operational improvements, and market consolidation,” said Steve Jia, Partner at HSG.
PeierTech首席执行官沈艾米表示，HSG的投资将为公司下一阶段的增长提供资金支持、国际经验和行业网络。
PeierTech chief executive Amy Shen said HSG’s investment would provide financial support, international experience and an industry network for its next phase of growth.
根据HSG披露，截至2026年6月30日，该公司管理的资产超过610亿美元，服务于机构投资者。自2005年成立以来，HSG已在科技、医疗健康和消费领域投资了1800多家公司。
HSG manages more than $61 billion in assets for institutional investors as of June 30, 2026, according to the firm. Since its founding in 2005, it has backed more than 1,800 companies across technology, healthcare and consumer sectors.